# ZYNERBA PHARMACEUTICALS INC (ZYNE)

> Institutional ownership reported to the SEC as of Q1 2024, from Form 13F filings. Source: https://holderbook.com/stocks/ZYNE/

- Reporting holders: 1
- Reported value: $16.2K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [B. Riley Wealth Advisors, Inc.](https://holderbook.com/funds/1464811-b-riley-wealth-advisors-inc/) | $16.2K | 12,732 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2024 | 1 | $16.2K |
| Q3 2023 | 44 | $14.8M |
| Q2 2023 | 40 | $1.7M |
| Q1 2023 | 42 | $2.8M |
| Q4 2022 | 47 | $4.3M |
| Q3 2022 | 50 | $8.1M |
| Q2 2022 | 44 | $12.7M |
| Q1 2022 | 49 | $27.8M |
| Q4 2021 | 53 | $41.2M |
| Q3 2021 | 54 | $60.5M |
| Q2 2021 | 66 | $84.4M |
| Q1 2021 | 61 | $49.6M |